1. Home
  2. IRWD vs EGY Comparison

IRWD vs EGY Comparison

Compare IRWD & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • EGY
  • Stock Information
  • Founded
  • IRWD 1998
  • EGY 1985
  • Country
  • IRWD United States
  • EGY United States
  • Employees
  • IRWD N/A
  • EGY N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • EGY Oil & Gas Production
  • Sector
  • IRWD Health Care
  • EGY Energy
  • Exchange
  • IRWD Nasdaq
  • EGY Nasdaq
  • Market Cap
  • IRWD 510.5M
  • EGY 497.4M
  • IPO Year
  • IRWD 2010
  • EGY N/A
  • Fundamental
  • Price
  • IRWD $3.53
  • EGY $4.73
  • Analyst Decision
  • IRWD Buy
  • EGY Strong Buy
  • Analyst Count
  • IRWD 4
  • EGY 1
  • Target Price
  • IRWD $12.00
  • EGY $8.00
  • AVG Volume (30 Days)
  • IRWD 1.9M
  • EGY 1.0M
  • Earning Date
  • IRWD 02-13-2025
  • EGY 11-11-2024
  • Dividend Yield
  • IRWD N/A
  • EGY 5.31%
  • EPS Growth
  • IRWD N/A
  • EGY 170.05
  • EPS
  • IRWD N/A
  • EGY 0.86
  • Revenue
  • IRWD $378,418,000.00
  • EGY $506,421,000.00
  • Revenue This Year
  • IRWD N/A
  • EGY $0.48
  • Revenue Next Year
  • IRWD N/A
  • EGY N/A
  • P/E Ratio
  • IRWD N/A
  • EGY $5.48
  • Revenue Growth
  • IRWD N/A
  • EGY 25.82
  • 52 Week Low
  • IRWD $3.06
  • EGY $4.03
  • 52 Week High
  • IRWD $15.70
  • EGY $7.51
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 44.66
  • EGY 32.96
  • Support Level
  • IRWD $3.39
  • EGY $4.74
  • Resistance Level
  • IRWD $4.05
  • EGY $5.08
  • Average True Range (ATR)
  • IRWD 0.30
  • EGY 0.18
  • MACD
  • IRWD 0.02
  • EGY -0.00
  • Stochastic Oscillator
  • IRWD 47.47
  • EGY 21.91

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea and Corporate and Other. The company generates maximum revenue from the Gabon segment.

Share on Social Networks: